National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 6658-6659 [2021-01264]
Download as PDF
<![CDATA[
6658
Federal Register / Vol. 86, No. 13 / Friday, January 22, 2021 / Notices
comments or requesting information,
please include the document identifier
0990–New–30D and project title for
reference.
SUPPLEMENTARY INFORMATION: Interested
persons are invited to send comments
regarding this burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
Title of the Collection: HHS
Teletracking COVID–19 Portal (U.S.
Healthcare COVID–19 Portal).
Type of Collection: In use without an
OMB number: OMB No. 0990–XXXX
OS/OCIO.
Abstract: The data collected through
this ICR informs the Federal
Government’s understanding of disease
patterns and furthers the development
of policies for prevention and control of
disease spread and impact related to the
2019 Novel Coronavirus (COVID–19).
One of the most important uses of the
data collected through this ICR is to
determine critical allocations of limited
supplies (e.g., protective equipment and
medication). For instance, this
collection has been used to distribute
Remdesivir, a vital therapeutic that HHS
distributes to the American healthcare
system, via distinct data calls on regular
intervals. As of July 10, HHS reduced
the number requests for data from
hospitals to support allocations of
Remdesivir. HHS has stopped sending
out one-time requests for data to aid in
the distribution of Remdesivir or any
other treatments or supplies. This
consolidated daily reporting is the only
mechanism used for the distribution
calculations, and daily reports are
needed to ensure accurate calculations.
Type of respondent: We acknowledge
the burden placed on many hospitals,
including resource constraints, and have
allowed for some flexibilities, such as
back-submissions or submitting every
business days, with the understanding
that respondents may not have
sufficient staff working over the
weekend. It is our belief that collection
of this information daily is the most
effective way to detect outbreaks and
needs for Federal assistance over time,
by hospital and geographical area, and
to alert the appropriate officials for
action. It’s requested that 5,500
hospitals, submit data daily on the
number of patients tested for COVID–19,
as well as information on bed capacity
and requirements for other supplies.
The HHS Teletracking COVID–19
Portal (U.S. Healthcare COVID–19
Portal) includes some data that were
initially submitted by hospitals to HHS
through CDC’s National Healthcare
Safety Network (NHSN) COVID–19
Module (OMB Control No. 0920–1290,
approved 03/26/2020). Over the last
several months time, the guidance for
which data elements should be sent to
HHS and through which method was
updated at the request of the White
House Coronavirus Task Force and
other leaders to better inform the
response.
ANNUALIZED BURDEN HOUR TABLE
Average
burden per
response
(in hours)
Total burden
hours
Form name
Hospitals ...........................................
HHS Teletracking COVID–19 Portal
(U.S. Healthcare COVID–19 Portal).
5,500
365
1.5
3,011,250
Total ...........................................
...........................................................
........................
........................
........................
3,011,250
Dated: January 14, 2021.
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2021–01323 Filed 1–21–21; 8:45 am]
BILLING CODE 4150–04–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
jbell on DSKJLSW7X2PROD with NOTICES
Number
responses per
respondent
Number of
respondents
Type of respondent
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Sep<11>2014
19:27 Jan 21, 2021
Jkt 253001
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Subcommittee.
Date: March 5, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6710B
Rockledge Drive, Bethesda, MD 20817
(Video-Assisted Meeting).
Contact Person: Luis E. Dettin, Ph.D., M.S.,
M.A., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6710B Rockledge
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Drive, Rm. 2131B, Bethesda, MD 20892, (301)
827–8231, luis_dettin@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: January 14, 2021.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–01262 Filed 1–21–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Dental &
Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\22JAN1.SGM
22JAN1
Federal Register / Vol. 86, No. 13 / Friday, January 22, 2021 / Notices
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel; Review of Institutional
Training Grant Applications.
Date: March 2, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
664, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute of Dental and
Craniofacial Research, National Institutes of
Health, 6701 Democracy Boulevard, Suite
664, Bethesda, MD 20892, 301–402–8559,
jimok.kim@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: January 14, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–01264 Filed 1–21–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
jbell on DSKJLSW7X2PROD with NOTICES
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
VerDate Sep<11>2014
19:27 Jan 21, 2021
Jkt 253001
Name of Committee: Biobehavioral and
Behavioral Processes Integrated Review
Group; Adult Psychopathology and Disorders
of Aging Study Section.
Date: February 11–12, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Benjamin Greenberg
Shapero, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 3182, MSC 7848, Bethesda, MD 20892,
(301) 402–4786, shaperobg@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Adult
Psychopathology and Disorders of Aging.
Date: February 12, 2021.
Time: 9:00 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
MSC 7848, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Hemostasis,
Thrombosis, Blood Cells and Transfusion.
Date: February 16, 2021.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine M. Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0912, Katherine_Malinda@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cancer, Heart, and Sleep Epidemiology B
Study Section.
Date: February 18–19, 2021.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Gianina Ramona
Dumitrescu, Ph.D., MPH, Scientific Review
Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 4193–C, Bethesda, MD 28092,
301–827–0696, dumitrescurg@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group;
Social Psychology, Personality and
Interpersonal Processes Study Section.
Date: February 18–19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
6659
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Marc Boulay, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3110,
MSC 7808, Bethesda, MD 20892, (301) 300–
6541, boulaymg@csr.nih.gov.
Name of Committee: Endocrinology,
Metabolism, Nutrition and Reproductive
Sciences Integrated Review Group;
Integrative and Clinical Endocrinology and
Reproduction Study Section.
Date: February 18–19, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Cardiovascular and
Respiratory Sciences Integrated Review
Group; Clinical Integrative Cardiovascular
and Hematological Sciences Study Section.
Date: February 18–19, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Margaret Chandler, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4126,
MSC 7814, Bethesda, MD 20892, (301) 435–
1743, margaret.chandler@nih.gov.
Name of Committee: Infectious Diseases
and Microbiology Integrated Review Group;
Cellular and Molecular Immunology—A
Study Section.
Date: February 18–19, 2021.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammad Samiul Alam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809D,
Bethesda, MD 20892, (301) 435–1199,
alammos@csr.nih.gov.
Name of Committee: Biology of
Development and Aging Integrated Review
Group; Developmental Therapeutics Study
Section.
Date: February 18–19, 2021.
Time: 9:30 a.m. to 7:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Nicholas J. Donato, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
E:\FR\FM\22JAN1.SGM
22JAN1
]]>Agencies
[Federal Register Volume 86, Number 13 (Friday, January 22, 2021)]
[Notices]
[Pages 6658-6659]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-01264]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Dental & Craniofacial Research; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
[[Page 6659]]
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Dental and Craniofacial
Research Special Emphasis Panel; Review of Institutional Training
Grant Applications.
Date: March 2, 2021.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Dental and Craniofacial Research,
National Institutes of Health, 6701 Democracy Boulevard, Suite 664,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jimok Kim, Ph.D., Scientific Review Officer,
Scientific Review Branch, National Institute of Dental and
Craniofacial Research, National Institutes of Health, 6701 Democracy
Boulevard, Suite 664, Bethesda, MD 20892, 301-402-8559,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral
Diseases and Disorders Research, National Institutes of Health, HHS)
Dated: January 14, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-01264 Filed 1-21-21; 8:45 am]
BILLING CODE 4140-01-P
